Bone Growth Stimulator Market size, Industry Analysis and Forecast to 2022

[153 Pages Report] The global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.\n\n\nThe growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.\n\n\nDon’t miss out on business opportunities in Bone Growth Stimulator Market.\n\n\nBone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.\n\n\nMarket Drivers:\n\n\n\n\t\nGrowing patient preference for noninvasive and minimally invasive surgical treatments\n\t\nIncreasing target patient population\n\t\nProcedural benefits offered by bone stimulation devices in bone fracture treatment\n\n\n\nSpeak to our analyst and gain crucial industry insights that will help your business grow:\n\n\nhttps://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383\n\n\nThe Major Objectives of the study:\n\n\n\n\t\nTo define, describe, and forecast the global Bone Growth Stimulator Market on the basis of product, application, and end user\n\t\nTo provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)\n\t\nTo strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market\n\t\nTo analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders\n\t\nTo provide market size for various segments of the Bone Growth Stimulator Market with respect to four main geographies, namely, North America (U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and Rest of the World\n\n\n\nBrowse and in-depth TOC on “Bone Growth Stimulator Market”\n\n\n66 — Tables\n\n\n67 — Figures\n\n\n153 — Pages\n\n\nView more detailed TOC @\n\n\nhttps://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-82341383.html\n\n\nMajor Market Developments:\n\n\n\n\t\nIn 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.\n\t\nIn 2016, Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion\n\n\n\nThe market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.\n\n\nRequest for Free Sample Report @\n\n\nhttps://www.marketsandmarkets.com/requestsample.asp?id=82341383\n\n\nOrthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the Bone Growth Stimulator Market.\n\n\nBrowse Adjacent Markets @ Medical Devices Market Research Reports & Consulting\n\n\nAbout MarketsandMarkets™\n\n\nMarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.\n\n\nOur 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.\n\n\nMarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.\n\n\nContact Us:\n Mr. Shelly Singh\n MarketsandMarkets™ INC.\n 630 Dundee Road\n Suite 430\n Northbrook, IL 60062\n USA: +1–888–600–6441\n Email: sales@marketsandmarkets.com

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.